JUBLPHARMA Ready for an Up Move?
Hello fellow traders, I hope you are all doing well.
Key Observations:
1. Strong Support Zone: JUBLPHARMA has reached a strong zone that previously acted as resistance and could now turn into support.
2. Chart Pattern: A falling wedge pattern is visible, which is typically a bullish reversal signal. We can also see that the breakout has already happened and now the price has come to retest.
3. Bullish Engulfing Candle: On the weekly time frame, we see buying pressure emerging, confirmed by a Bullish Engulfing candle.
4. Entry Point: A good entry could be above ₹1010 for better confirmation of the uptrend.
5. Targets: The potential targets are already marked on the chart as T1, T2, and T3.
As this is my first published idea, I kindly ask you to ignore any mistakes, and I will strive to improve in the future.
Disclaimer:
This is purely an analysis and not investment advice. Please trade with due diligence and manage your risks carefully.
I hope you like my work, Thanks in advance.
Best regards - Anantesh
Key Observations:
1. Strong Support Zone: JUBLPHARMA has reached a strong zone that previously acted as resistance and could now turn into support.
2. Chart Pattern: A falling wedge pattern is visible, which is typically a bullish reversal signal. We can also see that the breakout has already happened and now the price has come to retest.
3. Bullish Engulfing Candle: On the weekly time frame, we see buying pressure emerging, confirmed by a Bullish Engulfing candle.
4. Entry Point: A good entry could be above ₹1010 for better confirmation of the uptrend.
5. Targets: The potential targets are already marked on the chart as T1, T2, and T3.
As this is my first published idea, I kindly ask you to ignore any mistakes, and I will strive to improve in the future.
Disclaimer:
This is purely an analysis and not investment advice. Please trade with due diligence and manage your risks carefully.
I hope you like my work, Thanks in advance.
Best regards - Anantesh
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.